PRLD Stock Analysis: Buy, Sell, or Hold?
PRLD - Prelude Therapeutics Incorporated
$1.85
-0.05 (-2.63%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 09, 2026
Get Alerted When PRLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRLD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PRLD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PRLD is currently trading at $1.85, which is considered oversold relative to its 30-day fair value range of $1.94 to $2.67.
Technical Outlook: Technically, PRLD is in a uptrend. Immediate support is located at $1.76, while resistance sits at $2.30.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+116.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRLD is in a uptrend. Immediate support is located at $1.76, while resistance sits at $2.30.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+116.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.94 -
$2.67
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 116.2% below Wall St target ($4.00)
- CAUTION: Recommendation downgraded due to -8.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.94 -
$2.67
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.77
Resistance Level
$2.30
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.62
Wall Street Target
$4.00
(+116.2%)
Revenue Growth (YoY)
116.7%
Last updated: February 01, 2026 5:16 PM ET
Data refreshes hourly during market hours. Next update: 6:16 PM
Data refreshes hourly during market hours. Next update: 6:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
